US equities |
SPCX $171.09 ▲+0.00% MU $1,063.96 ▲+0.00% NVDA $238.90 ▲+0.00% META $741.90 ▲+0.00% AMD $631.75 ▲+0.00% AMZN $251.40 ▲+0.00% INTC $116.19 ▲+0.00% STX $887.09 ▲+0.00%
FinancialContent

Latest News about MAIA Biotechnology

Recent news which mentions MAIA Biotechnology

Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA
Tickers MAIA
Tags Benzinga All Access General MAIA
From Benzinga
MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer
Tickers MAIA
Tags Benzinga MAIA General
From Benzinga